published meta-analysis   sensitivity analysis   studies

corticosteroids in COVID 19 hospitalized - Summary of results

OutcomeTE95% CInkI2ROBPub. bias death D28detailed resultsGLUCOCOVID, 2020 0.63 [0.25; 1.60] Jamaati, 2021 1.19 [0.38; 3.72] REMAP-CAP, fixed 7-day course, 2020 1.03 [0.54; 1.98] REMAP-CAP, shock-dependent course, 2020 1.10 [0.58; 2.10] 0.98[0.67; 1.45]GLUCOCOVID, 2020, Jamaati, 2021, REMAP-CAP, fixed 7-day course, 2020, REMAP-CAP, shock-dependent course, 202040%590seriousnot evaluable deathsdetailed resultsCODEX (Tomazini), 2020 0.97 [0.72; 1.31] DEXA-COVID19, 2020 2.00 [0.21; 18.87] Edalatifard, 2020 0.29 [0.15; 0.56] GLUCOCOVID, 2020 0.63 [0.25; 1.60] Jamaati, 2021 1.19 [0.38; 3.72] RECOVERY dexamethasone, 2020 0.83 [0.75; 0.92] REMAP-CAP, fixed 7-day course, 2020 0.94 [0.61; 1.45] REMAP-CAP, shock-dependent course, 2020 0.98 [0.63; 1.53] Steroids-SARI, 2020 0.91 [0.29; 2.86] 0.83[0.67; 1.02]CODEX (Tomazini), 2020, DEXA-COVID19, 2020, Edalatifard, 2020, GLUCOCOVID, 2020, Jamaati, 2021, RECOVERY dexamethasone, 2020, REMAP-CAP, fixed 7-day course, 2020, REMAP-CAP, shock-dependent course, 2020, Steroids-SARI, 2020940%7,463moderatenot evaluable deaths (time to event analysis only)detailed resultsEdalatifard, 2020 0.29 [0.15; 0.56] REMAP-CAP, fixed 7-day course, 2020 0.94 [0.61; 1.45] REMAP-CAP, shock-dependent course, 2020 0.98 [0.63; 1.53] 0.67[0.35; 1.31]Edalatifard, 2020, REMAP-CAP, fixed 7-day course, 2020, REMAP-CAP, shock-dependent course, 2020381%560seriousnot evaluable clinical deteriorationdetailed resultsCODEX (Tomazini), 2020 0.66 [0.43; 1.02] 0.66[0.43; 1.02]CODEX (Tomazini), 202010%299NAnot evaluable clinical improvementdetailed resultsEdalatifard, 2020 12.00 [2.39; 60.20] REMAP-CAP, fixed 7-day course, 2020 1.43 [0.91; 2.26] REMAP-CAP, shock-dependent course, 2020 1.22 [0.76; 1.95] 1.81[0.89; 3.70]Edalatifard, 2020, REMAP-CAP, fixed 7-day course, 2020, REMAP-CAP, shock-dependent course, 2020372%600seriousnot evaluable clinical improvement (14-day)detailed resultsREMAP-CAP, fixed 7-day course, 2020 1.29 [0.82; 2.03] REMAP-CAP, shock-dependent course, 2020 1.03 [0.65; 1.64] 1.16[0.84; 1.60]REMAP-CAP, fixed 7-day course, 2020, REMAP-CAP, shock-dependent course, 202020%498seriousnot evaluable death or ventilationdetailed resultsRECOVERY dexamethasone, 2020 0.92 [0.84; 1.01] REMAP-CAP, fixed 7-day course, 2020 2.74 [1.16; 6.46] REMAP-CAP, shock-dependent course, 2020 1.24 [0.55; 2.78] 1.31[0.70; 2.46]RECOVERY dexamethasone, 2020, REMAP-CAP, fixed 7-day course, 2020, REMAP-CAP, shock-dependent course, 2020370%5,634seriousnot evaluable hospital dischargedetailed resultsRECOVERY dexamethasone, 2020 1.10 [1.03; 1.17] 1.10[1.03; 1.17]RECOVERY dexamethasone, 202010%6,425NAnot evaluable mechanical ventilationdetailed resultsJamaati, 2021 1.38 [0.45; 4.20] RECOVERY dexamethasone, 2020 0.77 [0.62; 0.95] 0.79[0.63; 0.99]Jamaati, 2021, RECOVERY dexamethasone, 202021%5,468moderatenot evaluable radiologic improvement (14-day)detailed resultsJamaati, 2021 4.89 [1.15; 20.79] 4.89[1.15; 20.79]Jamaati, 202110%50NAnot evaluable ICU admissiondetailed resultsGLUCOCOVID, 2020 0.85 [0.27; 2.67] 0.85[0.27; 2.67]GLUCOCOVID, 202010%64NAnot evaluable serious adverse eventsdetailed resultsCODEX (Tomazini), 2020 0.53 [0.17; 1.62] Edalatifard, 2020 0.81 [0.11; 6.17] REMAP-CAP, fixed 7-day course, 2020 3.01 [0.33; 27.32] REMAP-CAP, shock-dependent course, 2020 3.68 [0.42; 31.96] 1.06[0.41; 2.77]CODEX (Tomazini), 2020, Edalatifard, 2020, REMAP-CAP, fixed 7-day course, 2020, REMAP-CAP, shock-dependent course, 2020417%841seriousnot evaluable0.510.01.0relative treatment effectwww.metaEvidence.org2024-05-02 14:42 +02:00

TE: relative treatment effect (measured by a risk ratio, an odds ratio or an hazard ratio depending on what is reported in the papers); k: number of studies; n: total number of patients; ROB: risk of bias (ROB 2.0); Pub. bias: publication bias; OBS: observational studies; RCT: randomized clinical trials
studied treatment is better when TE > 1; studied treatment is better when TE < 1;

pathologies: 95,94,90,91 - treatments: 522,582,666,1149,1150,737,544,733 - roots T: 290